The world's first independent laboratory devoted solely to the development of an linkurl:AIDS; vaccine opens today (Nov. 12) in Brooklyn, New York. The new facility represents a new front in the effort to create an AIDS vaccine after recent, high profile clinical trial linkurl:failures; of vaccine candidates. The linkurl:International AIDS Vaccine Initiative's; (IAVI) AIDS Vaccine Design and Development Laboratory will be the first lab to take residence in the New York Science Center, or BioBAT, which takes its name from the sprawling linkurl:Brooklyn Army Terminal,; in which it is nestled. The approximately 38,000 square foot linkurl:BSL3; lab will initially focus on developing replicating vectors for an AIDS vaccine. "What they're trying to do is look at a whole range of replicating vectors and running them through a sieve," evaluating their safety, specificity, stability, and ability to transport an antigen, IAVI president linkurl:Seth Berkeley; told __The Scientist__. The lab, Berkley said,...

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?